SMARCA4 deficient carcinoma is thought to have a neuroendocrine origin, while SMARCB1 deficient carcinoma represents an emerging poorly differentiated/undifferentiated sinonasal carcinoma. This evidence concerns the gene SMARCA4 and carcinoma.